Recall D-0391-2025

US Class II Ongoing · initiated 2025-04-18

Recalling firm

Preferred Pharmaceuticals, Inc., CA

Product

Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, NDC 68788-8685-03.

Reason for recall

cGMP Deviations

← All recalls